Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions

NCT07391982 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Adenocarcinoma)

Interventions

RADIATION: uniform dose radiotherapy
RADIATION: De-escalated dose radiotherapy

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]